INTRODUCTION:

Nanofibers (Fig.1) are ultrafine fibers consisting of natural or synthetic polymers that can be obtained by several different processes, including electrospinning 2, solution blowing 3, self-assembly and phase separation 4. They are generally narrower than 1000nm. Nanofibers have been widely studied as biological materials owing to their high surface-to-volume ratio, tunable porosity, and structural homology with extracellular matrix (ECM)¹. At the moment, electrospinning remains the most versatile and popular of all the fabrication methods because it allows you to control how porous or dense the fibers are, incorporate drugs into them and create more of them. The appropriate strength, wettability and degrading behavior of the scaffolds can be achieved by a fine-tuning of the physicochemical properties (e.g., diameter, orientation, surface functionality and porosity) of the nanofibers². Nanofibers are excellent agents of giving drugs, filtering things, healing wounds, doing regenerative medicine and biosensing^2,3.

Figure 1: The structure of nanofibers³.

Drug Delivery and Tissue Engineering Applications:

These nanofibers serve as smart drug delivery systems, which can carry proteins, nucleic acids and small molecules and release them in a controlled, localized manner for an extended period of time. The large surface area and interconnected pores provide the opportunity for multi-drug release and delivery. Moreover, coaxial and core-shell nanofiber structures can enable drugs to be released sequentially or at specific intervals, and they can protect vulnerable drugs from degradation⁴. Due to numerous available polymers, the therapeutic effects can be enhanced via controlling the degradation rate and drug-polymer interactions.

Nanofiber-treated tissue engineering offers a support environment that can enhance cell adhesion, growth and differentiation into one natural extracellular matrix (ECM) fibrous structure. Functionalized with growth factors or bioactive substances, they function as scaffolds that regulate cell organization and tissue regeneration providing, in addition to mechanical support, also biochemical signals.⁵ Nanofibers are one of the most potential biomaterials in modern biomedical engineering for they can couple the design of regeneration scaffolds with drugs controlled delivery^1-3.

The Review’s Scope and Structure:

This review examines the current status and potential applications of nanofiber technology in drug delivery and tissue engineering. It starts with the introduction to nanofibers, their unique characteristics, behavior and properties as well as their various applications. The following sections discuss biocompatibility and in-vivo performance, nanofiber scaffolds for tissue engineering, drug loading with nanofibers, challenges and limitations, and novel technologies such as smart and 3D-printed nanofiber systems. The objective of this work is to showcase how nanofibers can enable novel applications in next-generation biomedical devices and therapies by including the state of the art from open-access articles.

Basic Principles of Nanofibers:

Features and Benefits:

Nanofiber Nanofibers are long and ultra thin fibers typically with diameter of 50-1000nm. This makes them have large surface area to volume ratio, and porosity which interconnect all of them Why biochar? These have enhanced cell adhesion, molecule adsorption and mass transfer that all are critical contributors to drug loading as well a tissue scaffolding⁶.

Their porosity (more than 80–90% total porosity) can be tuned by varying the concentration of the solution, voltage, flow rate and collector design during electrospinning. It enables differential alteration of diffusing and mechanical properties to match either delicate tissues or stiffer loadbearing structures⁷.

The surface of nanofiber can be chemically modified (e.g., by plasma treatment, polydopamine coating or ligand grafting) to control their hydrophilicity and fixed biomolecules or sensitize them to external stimuli such as pH, enzymes or light. As a result, bio integration becomes stronger and drug release is more controllable⁸.

Electrospinning is considered, from a processing perspective, as a simple and scalable top-down technique which provides homogeneous fibers made of various polymers, blend and hybrids at higher purity levels than many bottom-up nanomanufacturing processes⁹.

Why this is important in biomedicine. It has a large surface area, enabling drug loading in high quantities and immobilization of protein rapidly. Interconnected holes also allow for nutrients to pass through the material and cells to migrate in. The fibrous structure resembles the native extracellular matrix (ECM) and encourages cells to adhere to it, and differentiate into specific lineage^7,8.

Comparison with other Nanostructures:

Against nanoparticles (NPs). NPs are very good at getting into the body and passing through biological barriers. But mats of nanofibers tend to release what’s inside them more slowly and in a more controlled manner, with fewer bursts, because the paths are longer and the matrix Is tangled. They also help carry cargo to a target, such as a wound bed, and act as a scaffold which free-floating NPs cannote¹⁰.

Compared to hydrogels and nanogels. (These are substances that have a lot of water content and act like soft tissue, but which may be weak mechanically and through which drugs can move easily because passages are so tiny.) Electrospun nanofibers provide improved tensile strength and the possibility of tuning anisotropy by controlling fiber orientation, in addition to ease of gradient patterning via spatial organization. The combination of fibers with hydrogels, either in the form of fiber-reinforced or interpenetrated networks, often leads to enhanced cell guidance, cell retention and release¹¹.

As compared to 3D printed lattices and porous foams. While foams and printed lattices offer macro porosity and precise shape, the strut dimensions are frequently an order of magnitude larger than those of native fibrillar ECM. Microfibrillar signals in the sub-micrometer scale that regulate focal adhesion formation and mechanotransduction are uniquely recapitulated through nanofiber, which might be critical to stem cell lineage specification in tissue engineering¹².

Materials for Nanofibers:

Polysaccharides, synthetic polymers and polymer composites are the dominating materials for nanofiber production. Chitosan, gelatin, and collagen are natural polymers that are excellent for tissue engineering as they are biocompatible and biodegradable. Synthetic polymers such as PCL, PLA, PLGA and PEG are stronger, degrade in a controlled manner and can be reprocessed. Biohybrid or composite materials which incorporates the biological advantages of natural polymers with the stability of synthetic ones. This makes them very attractive for drug delivery and regenerative medicine¹³.

Strategies for functionalization:

By blending, coaxial or multifluid electrospinning could be a used to develop the pharmaceuticals or produce core-shell fibers that burst release drugs, sustain-release drugs or activated-drugs.

Post-spinning surface modification (plasma, polydopamine, click chemistry) with growth factors, peptides or nanoparticles for bioactivity and sensing¹⁴.

How to make things:

Nanofiber production has come a long way in the past two decades, and it is now possible to very precisely control the diameter, alignment, porosity, and composition of the resulting fibers. How such processes of rendering the particles aid in making the resulting nanofiber, alter its mechanical strength or rate of degradation and influence whether it is good at releasing drugs are all important for biological applications such as drug delivery and tissue engineering.

Electrospinning: Basics and Variations:

The most widely used and versatile approach to fabricate nanofibers is electrospinning. It uses static electricity to draw a polymer solution or melt into extremely fine fibers. Once a high voltage is applied across the spinneret and collector, charged polymer droplet on the needle tip becomes Taylor cone. If the electrostatic force is greater than surface tension then a fine jet gets ejected. It becomes elongated and hardened as the solvent vaporizes out¹⁵.

The process parameters, e.g., solution viscosity, voltage, the distance between tip and collector and feed rate directly affect the morphology of fiber. You can modify the fiber diameter, porosity and drug encapsulation efficiency by altering those parameters¹⁶.

Different Kinds of Electrospinning:

Updated electrospinning methods now exist that are also suitable for fiber structure, drug distribution and scale-up:

The coaxial electrospinning produces core-shell fibers which are capable of controlled drug release, protect vulnerable biomolecules, and carry two drugs simultaneously¹⁷.

Emulsion Electrospinning: This technique employs water-in-oil or oil-in-water emulsions to encapsulate hydrophilic and hydrophobic drugs as separate phases with one needle^16,17.

Melt Electrospinning Instead of toxic solvents, the polymer is melted which makes it particularly suitable for thermoplastic biomaterials but with a restriction in maximum amount per processing steps¹⁸.

Needleless and Multineedle Electrospinning: Easier production of more attractive products as well as simple scaling up for industrial applications¹⁹.

Electrospinning using Magnetic or Rotating Collectors: As an electrically driven process this spinning technique can be used to align the fibers in a manner that is reminiscent of anisotropic structures (e.g. muscle or nerve cells)^16-19.

The technique of electrospinning is attractive in biomedicine due to its ease, affordability, and applicability to numerous natural and synthetic polymers²⁰.

Figure 2: A chart shows how industry uses electrospinning²¹.

Other Methods (e.g. Solution Blowing and Self-Assembly):

The most common method for making nanofibers is a process called electrospinning, but several newer methods come with additional advantages, such as higher throughput and more flexible solvents^19-20.

Blowing Solutions:

Here, the electric field is replaced by a high-speed gas flow which stretches fibers from a polymer solution. It can be produced in high volume, and doesn’t require a high-voltage power source, so it is safer and requires less energy. But the fibers that are formed aren’t usually as uniform as those electrospun. Solution blowing is an effective method to produce wound dressings and filter mats in high yields²².

Self-Assembly:

This bottom-top construction makes molecules go together to form fibrous nanostructures by molecular interactions, such as ion contacts, hydrogen bonds or hydrophobic forces. Peptide-based nanofibers for neuronal regeneration and targeted drug delivery are also investigated by the researchers. This is because they can replicate biological scaffolds and be used to encapsulate drug without rigorous preparation²³.

Template Synthesis and Phase Separation:

During spinodal de-mixing, a polymer solution undergoes thermally induced phase separation and when the solvent is removed, it leads to hyper-branched fibrous structures. This process produces ECM-like, porous structures that are, however, not as controllable as electrospinning²⁴. The template synthesis, the porous molds or nanoporous membranes and subsequent its removal^21,22.

Surface Modification and Functionalization:

Post-synthetic functionalization is required for tailoring the biophysical and biological properties of nanofibers, enhancing cell adhesion, drug entrapment and their biocompatibility.

Chemical Functionalization:

Reactive group (–COOH, –NH₂ and –OH) can be introduced onto the surface of nanofibers by a plasma treatment, salinization or graft polymerization. These groups serve as anchors for biomolecules, peptides or drugs facilitating cell attachment and enhancing bioactivity of cells²⁵.

Physical material layering and deposition:

Dip coating, layer-by-layer assembly and polydopamine coating are all methods to apply functional chemicals, nanoparticles or hydrogels on the fibers without changing the original structure. For example, adding gelatin to PCL fibers renders them more hydrophilic and enhances cellular response²⁶.

Including nanoparticles and biomolecules:

For instance, silver, zinc oxide or hydroxyapatite nanoparticles introduce antibacterial, osteoconductive or electrical properties to fibers.^21,22 Similarly, surface conjugation may be useful for tailoring biological responses for tissue regeneration by immobilizing growth hormones (VEGF, BMP-2) or enzymes²⁷.

Nanofibers for Delivering Drugs:

Due to their specific fibrous nanostructure, high surface area and tunable porosity, nanofibers have proved very proficient for drug encapsulation and delivery to targeted sites²⁸. They are able to deliver many kinds of drugs such as small molecule drugs, protein/peptides and nucleic acids or nanomaterials in a controlled pattern, sustained manner or in response to external stimuli. They are great for transdermal, wound healing and implant-based delivery systems due to their extracellular matrix (ECM) mimicking nature²⁹.

Strategies for Loading Drugs:

How the medicine is loaded matters a great deal to how quickly it releases, how stable it is on average and how readily accessible the body makes it. Some common tactics are:

Mix Electrospinning:

Prior the electrospinning drug is dissolved or dispersed directly into the polymer solution. This approach is simple and routine, and it makes certain that the drugs are distributed homogeneously throughout the nanofibers³⁰.

However, it often causes an early burst released because the drug is near the fiber surface. Polymers such as PLGA and PCL are able to encapsulate hydro phobic drugs, such as curcumin or paclitaxel. Nonetheless, hydrophilic drugs might require surfactants or co-polymers³¹.

Electrospinning with coaxial wires:

Coaxial electrospinning yields core-shell nanofibers, with the medicine residing in the core and a protective layer of nothingness on the outside. Altogether, this configuration allows the biomolecules (proteins, peptides, DNA) to remain stable and to be protected from denaturation. For example, the core PVA/PCL shell fibers supplemented with insulin were capable of maintaining an euglycemia for 72 h (in vitro)³².

Electrospinning of Emulsions:

In this setup, the polymer and the medication are premixed with oil and water or water and oil before spinning. It can incorporate hydrophilic as well as lipophilic materials simultaneously. Fibers produced through emulsion are said to have less burst release and more stability for biologics including growth factors³³.

Post Loading (Surface Adsorption and Immersion):

Drugs can also be adhered to or coated on the nanofibers finished. This strategy is suitable for heat labile or fast changing molecules but might compromise the release of compounds in a less efficient way³⁴.

Layer and composite systems:

Multilayered fiber mats (for instance, a fast-release top layer and a slow-release base) can deliver drugs in two stages or consecutively. One advantage of this is for wound dressings, or combination therapy³⁵.

Governed and Focused Release:

The release behavior of nanofibers can be modulated in several ways:

Diffusion-controlled EDC is a function of the drug concentration gradient and porosity of the polymer.

Degradation-mediated release: When biodegradable polymers (for instance PLGA and PCL) dissolve, drugs loaded in these matrices are gradually released³⁶.

Swelling based release: Hydrophilic polymers, such as PVA and gelatin, upon hydration swell which pushes the drug out from matrix in a monolithic manner^30-34.

Targeting to the tumour tissue can be achieved by surface functionalization with ligands, such as antibodies, folic acid or peptides that specifically attach themselves to receptors. For instance, PCL-nanofiber with folic acids modified on their surfaces were specifically up taken by breast cancer lines when compared to normal cell lines so that they could be applied for tumor targeting chemotherapy in the future³⁷.

Magnetic sensitive nanofibers with embedded the iron oxide nanoparticles also permitted magnetically directed delivery and release in response to outside fields^28-30.

Intelligent and Stimuli-Responsive Systems:

Stimulus-responsive nanofibers: Novel constructs have been designed that cause nanofibers to shift their drug release behavior when the environment changes, including pH, temperature, light and enzymes³⁸.

pH-responsive fibers: These are designed for either tumors or wounds, and drugs can break down more rapidly under the acidic conditions or spread under the high pH of either site.

Temperature sensitive fibers: They utilize polymers such as poly(N-isopropylacrylamide) (PNIPAAm), which changes its solubility with temperature thereby facilitating pulse drug release^32,33.

Enzyme-responsive fibers: These fibers will degrade in the presence of enzymes such as collagenase or lipase. It enables the targeted release in a sick or inflamed tissue.

Photo-responsive systems: With photo-cleavable linkers or Au nanoparticles for NIR-triggered release³⁹.

Applications in Cancer Therapy, Skin Repair and Localized Release:

Nanofiber systems are especially critical for treating cancer, healing wounds and administering drugs to targeted sites on the body over time. Nanofibers can transport chemotherapy drugs to tumour tissues in cancer therapy. This reduces the systemic toxicity and enhances treatment efficacy⁴⁰. Their structure, which is similar to the ECM, helps cells stick together at a particular spot and maintain an optimal level of moisture while letting antibacterial or growth-promoting chemicals out in a controlled manner. Nanofibers act as implants or a bioactive agent for focused release, but to do this with less side effects by maintaining an enhanced concentration of medications in the site of action.

Nanofibers In Tissue Engineering:

Mimicking the ECM and Engineering a Scaffold:

The role of a tissue engineering scaffold is critically based on its capacity to resemble the native extracellular matrix (ECM) network of the target tissue. 55 Nanofibrous scaffolds resemble the fibrous architecture, nanosized dimension (typical fibre diameter at 50-300 nm), high surface area/volume ratio, and connectedness of the ECM that aids in adhesion and motility of cells as well as maintenance and differentiation to other lineages⁴³.

The design parameters range from the fibre diameter to their alignment/orientation, porosity/inter-fibres spacing, mechanical stiffness, surface chemistry (functional groups, bioactive moieties) and rate of degradation. For example, an aligned nanofiber scaffold can direct cell shape elongation, which is conducive to tissues such as nerve, tendon, muscle or ligament⁴⁴.

In the fibre network for composite scaffold formation, inorganic phases (eg, hydroxyapatite) or blends of natural and synthetic polymers can be incorporated to modulate the mechanical responses as well as bioactivity profiles that match bone, cartilage, and other load-bearing tissues⁴⁵.

Cell Adherence, Growth and Differentiation:

Nanofibrous mats the similarity of such orientation stone Moravec et al., soon impose to the structure of ECM fibrils which, in turn, facilitates early cell attachment Besides related essential ligands (e.g. RGD peptides, collagen motifs) on high surface areas is possible to be presented by nanofibrous scaffolds⁴⁶.

Upon attachment, the microenvironment of scaffold (stiffness, fibres orientation, degradation profile and bioactive signals) modulates subsequent proliferation and lineage determination. For example, stiffer scaffolds could stimulate osteogenic differentiation while softer or aligned designs may enhance neural or muscular phenotypes⁴⁷.

Many have found nanofiber scaffolds, that are functionalised with growth factors or surface modifications (such as immobilised peptides and nontopographical features) induce significantly higher levels of differentiation markers compared to untreated scaffolds⁴⁸.

Regeneration Applications for Bone, Skin, Nerves, and Cartilage:

Nanofiber scaffolds for bone regeneration often incorporate osteoconductive or osteo inductive cues such as hydroxyapatite nanoparticles added to a polymeric nanofiber matrix. These provide osteoblasts a place to anchor onto the surface as well as sites for mineralization and minimize differences in mechanical properties⁴⁹.

Skin (Wound Healing): Nanofiber mats act as short term ECM for skin regeneration. They promote the infiltration of keratinocytes and fibroblasts, moisten the zone and may also carry bacteriostatic or growth-factor payloads. Due to their high porosity and fibrous structure, they are suitable for the dressing or the skin scaffold.

Nerve/Neural tissue: The Topography of the aligned nanofiber scaffolds are NOT regular, which may allow for Schwann Cell Migration and Neurite Outgrowth. The neutrophil substances can be added to the nanofiber and neuronal recovery is further improved⁵⁰.

Cartilage: The blood doesn’t flow to cartilage and it is not good at repairing itself. Cartilage nanofiber scaffolding Scaffolds used for cartilage typically imitate the ECM fibrous architecture and are often loaded with bioactive agents to support chondrogenesis. Cartilage requires to be highly porous and mechanically stable because of its low cell number⁵¹.

Bioactive Nanofibers and Hybrid Scaffolds:

Hybrid scaffolds combine types of materials, or approaches to making things, like electrospinning and 3D printing, to achieve properties that work effectively in combination – mechanical strength; degradation rate correlated to tissue healing; bioactivity; control over drug/growth factor release.

‘Smart’ scaffolds: that can act both as a scaffold (providing mechanical support) and also provides signalling cues through incorporating drugs / peptides/ growth factors within nanofibers. For instance, coaxial electrospinning (core-shell fibres) allows bioactive agents to be encapsulated in the core while maintaining the surface morphology for cell interactions⁵².

In Vivo Behaviour and Translation Implication:

In vitro investigations of nanofiber scaffolds have been promising in terms of cell attachment, differentiation and mineralisation. However, when it comes to in vivo (and therefore clinical) application, settling of other issues such as; biocompatibility (immunogenicity, fibrous encapsulation), degradation products (toxicity, changes in pH), mechanical match with the tissue, 51 vascularisation rate cell/ tissue infiltration depth sterilization protocol etc., will become important considerations⁵³.

Nanofiber scaffolds can integrate with host tissue and promote the formation of tissue, as demonstrated in animal studies. Nonetheless, there are remaining issues that need to be addressed including the control of scaffold architecture for deep tissues repair versus surface defects, functional (as opposed to a sheer physical) regeneration and cost-effective approaches and reproducible techniques for scalability^50-53.

Compatibility with Biological Systems and In Vivo Results:

Biocompatibility is very important in the case of nanofiber materials designed for biomedical applications such as drug delivery and tissue engineering. It ensures that the nanofibrous scaffold or system is brought in contact with biological tissues without eliciting undesired immune or cytotoxic responses. For predicting the clinical relevance of nanofibers, it is necessary to examine biocompatibility and in vivo effectiveness⁵⁴.

Profiles of Degradation:

How these nanofibers degrade is very important to establish the stability and efficacy of these in vivo. PLA, PCL and PLGA are biodegradable polymers that are often used for the production of nanofibers as they degrade in such a way that it is easy to predict and known to be non-hazardous. In some cases, the degradation rate is desirably selected according to the application. That faster decomposition is more appropriate for temporary wound dressings, while a slower degradation would be best to serve as scaffolding that aids the regrowth of tissue over time^49-52.

The degradation of nanofibers is dependent on the polymer type, molecular weight, crystallinity and the incorporation of crosslinker/admixture. For instance, PCL nanofibers allow for slow degradation given that they are highly crystalline while PLGA nanofibers prompt fast degradation due to hydrolytic scission of ester bonds. Extracellular factors, such as pH, enzyme activity and local inflammation might also facilitate the degradation in vivo⁵⁵.

Responses of the Immune System:

A preferable nanofiber scaffold should have adhesion, proliferation, and differentiation for cells as well as immunological response inhibition. Features of nanofibers, such as surface chemistry (Ueno et al. 2010), shape, and topography, greatly impact the immune response. Smooth hydrophilic surfaces usually reduce protein adsorption and macrophage activation leading to improved biocompatibility⁵⁶.

Electrospun fibers composed of natural polymers, such as collagen, chitosan, silk fibroin and gelatin show great immunotolerance because they are biocompatible and homologous with the extracellular matrix (ECM)^41,42. But synthetic polymers generally have to be modified on the surface, or coated with biomolecules like peptides or growth factors, in order to enhance these interactions between cells and materials and reduce inflammation. It has been reported that anti-inflammatory drug (e.g., dexamethasone or curcumin) modified nanofiber scaffolds can further reduce the release of pro-inflammatory cytokines and enhance wound healing⁵⁷.

Pre- and Post-equivalence Evaluations:

The cytotoxicity, hemocompatibility and tissue integration of nanofiber systems are the dominant subjects regarding the preclinical evaluation in in vitro/in vivo experimental models. These tests are typically conducted in accordance with the ISO 10993 standard. MTT or Live/Dead assays are used for determining living cells. Hemolysis and platelet adhesion assays are used to conduct compatibility tests for blood^43,44.

In vivo testing on the animal models (rats or rabbits) are conducted to observe tissue response, degradation behaviour and drug release profiles. For instance, the electrospun PLGA nanofibers containing antibiotics have been shown that can release drugs in a controlled manner and reduce infection rate in wound models. Collagen/PCL hybrid nanofibers have also exhibited good tissue integration and minimal fibrotic encapsulation after being implanted under the skin⁵⁸.

While such scaffolds have demonstrated wound healing and tissue regeneration potential, nanofiber scaffolds remain underutilized in clinical practice. A few nanofiber dressings ((often incorporating silver nanoparticles or biologically active compounds) have reached clinical trials due to their strong antibacterial and wound healing properties^41-44.

Challenges and Limitations:

Nanofiber technology has come a long way and is extremely useful in biomedical applications, but there are still several issues that have made it difficult to commercialize or use in clinical settings. Most of these problems are associated with the manufacturability in large quantities, the reproducibility and quality control, regulatory aspect, and ethical concerns. It is crucial to recognize and address these issues in order to successfully apply nanofiber technologies in today's healthcare sector.

Manufacturing Things, and Making Them Larger:

Despite the fact that electrospinning is simple and versatile, it has lots of drawbacks in terms of large-scale production of nanofibers. Small quantity production (a few milligrams per hour) in traditional single-needle electrospinning makes it difficult for large-scale biomedical manufacturing. To address this issue, new techniques such as multi-needle, needleless and centrifugal electrospinning have been developed to enhance the throughputs⁵⁹.

Maintaining the shape, distribution of the diameter and porosity for fibers between manufacturing batches is still a huge challenge. Variations in the environment like humidity, temperature and electric field strength can greatly influence fibre properties. In addition, making the bioactive compounds (e.g., growth factors and drugs) be included in produced by large scale becomes very difficult to maintain their stability and distribute them equally throughout the nanofiber matrix^55-57.

A second challenge is assembly of hybrid or composite nanofibers, which generally must be fabricated through multiple steps and require delicate management of phase separation and interfacial bonding. As well, the cost of raw materials (specifically bio-medicinal polymers and solvents) and use of aseptic controlled environment make is difficult for commercial scaling and lowering production costs^51-55.

Quality Control and Reproducibility:

It is also critical to be able to create nanofibers repeatedly in order for them his therapeutics to work effectively. Minor variations in the very small of amount of polymer, viscosity of solution, or voltage applied can lead to significant difference in fiber structure and release profiles of drug^45,46. That uncertainty complicates the process of turning test results into clinically suitable products.

Standard quality control (QC) methodologies remain to be developed for nanofiber-based products. Currently, there is no worldwide consensus on the above parameters regarding biomedical nanofibers (such as fibres diameter range, mechanical strength, pore size or degradation rate). Real-time monitoring techniques such as in situ spectroscopy or high-speed camera imaging during the (electro)spinning are becoming an increasingly realistic option to stabilize and control the process⁶⁰.

In addition, the complexity of a multi-component nanofiber system (e.g., co-axial or core-shell structure) requires advanced analytical techniques, such as SEM, TEM and DSC to ensure structural and compositional uniformity^55-58.

Regulatory and Ethical Factors:

Still lacking are regulations for biomedical items made with nanofibers. Since by definition nanofibers are part medical device and part drug delivery system, regulatory authorities like the U.S. have had trouble figuring out how to classify them and get them approved. The Food and Drug Administration (FDA) and the European Medicines Agency (EMA)^45,46. Developers will need to provide a great deal of information about toxicity, biocompatibility, degradation and pharmacokinetics. That means they must conduct a great deal of testing in preparation for and during clinical trials.

In addition, ethical issues are very important, even more right for nanofibers to be applied upon implantation or regenerative purposes. The long-term biosafety, potential toxicity in nanoscale and environmental process of polymer degradation products are needed to complete considerately⁶¹. Ethical frameworks should also incorporate informed consent, replacement of animal testing and data transparency in clinical trials with complex nanomaterials.

Another challenge of regulation is that there exist no international standards for the characterization and labelling of nanoparticles. This has led to variations in assessment and approval in different countries, resulting in slow commercialization and increased research costs. It is essential for academia, industry, and government agencies to collaborate in order to develop appropriate guidelines for nanofiber based biomedical devices^59-61.

Future Outlook and New Developments:

There are rapid developments in the field of nanofiber technology, driven by advances in materials science, nanofabrication and biomedical engineering. The new generation values of the nanofiber-based systems will be personalization, smart reactivity and interaction with digital as well as electronic healthcare resources. These new advances offer to address the shortcomings we have today with respect to biocompatibility, scalability and clinical translation. This will enable to develop highly efficient therapies customized for the individual.

Personalized 3D Printed Nanofiber Scaffolds:

With recent advances in 3D printing and additive manufacturing, it is now feasible to fabricate custom unique nanofiber scaffolds to match the individual anatomy and physiology of each patient. These scaffolds can closely mimic the native ECM through the regulation of porosity, fiber, orientation and degradation rate. This helps tissues heal faster.

By adding electrospinning to 3D bioprinting, researchers can directly incorporate living cells, growth factors and bioactive molecules into the scaffold. This creates a hybrid system facilitating the re-growth of tissues such as bone, skin or cartilage in both structure and function^55,56.

Finally, investigators are also exploring the potential to leverage machine learning and artificial intelligence (AI) for more predictive scaffold design: will the fibers line up in a particular way, will they be strong enough, how quickly will they degrade^47-49. Such digital-facilitated personalisation is expected to significantly enhance the effectiveness of treatments in regenerative medicine.

Bio-Sensors and Wearables Compatibility:

Another exciting direction would be integrating nanofiber technologies with biosensors and wearable medical devices. Conductive or piezoelectric materials, such as P(VDF) and graphene composites nanofibers can acquire physiological data like the pH, glucose Sensors 2018, 18, x FOR PEER REVIEW 15 of 19 level and temperature providing real-time information back for the controlled medication release⁶².

These intelligent nanofiber platforms not only enable better drug administration, but they help us monitor our health on an ongoing basis particularly for diseases from which we suffer over long periods of time, like diabetes, heart disease and wound care.

Furthermore, nanofiber patches with built-in microelectronics have been developed for controlled drug delivery-based light/heat/electric-field stimulation^59-61. These sorts of devices align with a continuing movement toward more individualized, remote and automated medical care.

Nanofiber-Based Organs-on-Chips and Bioelectronics:

The emergence of organ-on-chip technology forms a new laying road for nanofibers in micro physiological systems. These nanofibers can act as ECMs in microfluidic chips to provide a biomimetic niche for cell manipulation and expansion. This integration allows a more realistic simulation of human organ functions, which is acting to increase the relevance of drug screening, toxicity testing and disease modelling compared with the traditional in vitro models. In addition, nanofiber-based bioelectronic interfaces cross interviewed conductive biodegradable polymers and electrospun fibers have been exploited for nerve regeneration, cardiac pacing and neural signal recording^54-58. These types of bioelectronic systems can link biological tissue with equipment outside the body, potentially leading to improved biomedical implants and prostheses.

Moving Toward Clinical Translation:

Nanofiber-based systems have done great work in the lab, but even getting them to the clinic is still a tremendous roadblock because of issues around regulatory approval of these devices, being able to generate them at large scale and safety over long periods⁶³.

Further investigation includes the development of scalable procedures and GMP-compliant protocols for clinical-grade nanofibers. Researchers, businesses and government agencies will have to collaborate on addressing ethical as well as safety concerns.

And those are just the start multi duty nanofibers able to deliver drugs, sense things and help heal the body itself are soon supposed to be providing a platform for the next generation of biomedical devices. Biocompatibility assessment, in vivo performance testing and predictive modelling will all improve with time, which will accelerate their deployment into the clinical setting⁶⁴.

The integration of nanotechnology with biotechnology (NB), and information technology (BT) will be the essential approach to realize tailor-made medicine by patterned nanofiber system.

CONCLUSION:

Recent years have witnessed nanofibers as a promising platform in biomedical research, such as tissue engineering and drug delivery. Due to their special structural advantages, such as high surface area and porosity, tunable shape control, it is possible for drugs to have the encapsulation effect accurately; they can be controlled in a long time release way and better interact with cells. This opportunity has been heightened recently by advances in fabrication processes and functionalization of materials for applications in wounds, cancer and regenerative medicine. Even though there have been major advances, transferring to the clinic remains difficult due to issues from mass production and reproducibility to regulatory approval. Further studies ought to now pay more attention on modifying to get better biocompatibility, methodizing production and guaranteeing safety of the material via thorough in vivo assessments.

REFERENCES:

1. Kumar L, Verma S, Joshi K. Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities. Future J Pharm Sci. 2021; 7:175.

2. Chen K, Li Y, Tan Y, Liu Y, Pan W, Tan G. Stimuli-responsive electrospun nanofibers for drug delivery, cancer therapy, wound dressing, and tissue engineering. J Nanobiotechnol. 2023; 21:237.

3. Uzel E, Durgun ME, Esentürk-Güzel I, Güngör S, Özsoy Y. Nanofibers in ocular drug targeting and tissue engineering: importance, advantages, and future perspectives. Pharmaceutics. 2023; 15(4): 1062.

4. Advancements in nanofibers and nanocomposites: cutting-edge innovations for tissue engineering and drug delivery – A review. Front Bioeng Biotechnol. 2023; 11: 1198521.

5. Haranath Chinthaginjala, Maddileti Repollu, Babji Naik Bhukya. Novel Drug Delivery Systems: An effective platform for Enhanced Therapy. Asian Journal of Pharmacy and Technology. 2024; 14(3): 257-3.

6. Bhattarai RS, Bachu RD, Boddu SHS, Bhaduri S. Biomedical applications of electrospun nanofibers: drug and nanoparticle delivery. Int J Nanomedicine. 2018; 13:6239–6255.

7. Chakrapani G, Vora SR, Manjunath K. Functionalization of electrospun nanofiber for biomedical applications. J Appl Polym Sci. 2023; 140(38): e53906.

8. Fadil F, Azman NF, Azmi AH. Review on electrospun nanofiber-applied products: limitations and solutions. Polymers. 2021;13(8):1280.

9. Shan X, Li X, Wang S. Nanoparticles Agarwal S, Greiner A, Wendorff JF. Functional materials by electrospinning of polymers. Prog Polym Sci. 2013;38(6):963–991.

10. vs nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro. Nano Rev Exp. 2015;6(1):28238.

11. Cao H, Duan L, Zhang Y, Cao J, Zhang K. Current hydrogel advances in physicochemical and biological response-oriented designs. Signal Transduct Target Ther. 2021; 6:426.

12. Choi H, Kim H, Park K. A review of advanced hydrogel applications for tissue engineering and regenerative medicine. Gels. 2024;10(11):693.

13. Haider A, Haider S, Kang IK. A comprehensive review summarizing the effect of electrospinning parameters and polymeric characteristics on the morphology of nanofibers. Adv Mater Sci Eng. 2018; 2018:1–18.

14. Yan B, Wan N, Zhang Y. Electrospun nanofibrous membrane for biomedical application. SN Appl Sci. 2022; 4:201.

15. Mayuri M. Shitole, Shailesh S. Dugam, Neha D. Desai, Rahul S. Tade, Sopan N. Nangare. Pharmaceutical Applications of Electrospun Nanofibers: A State-of-the-Art Review. Asian J. Pharm. Tech. 2020; 10(3):187-201.

16. Li D, Xia Y. Electrospinning of nanofibers: Adv Mater. 2004;16(14):1151–1170.

17. Yu DG, Wang M, Li XY. Electrospun biphasic drug release polyacrylonitrile nanofibers. J Control Release. 2019; 316:90–101.

18. Celebioglu A, Uyar T. Electrospinning of nanofibers from aqueous solutions: a review. Polymers (Basel). 2021;13(2):193.

19. Brown TD, Dalton PD, Hutmacher DW. Melt electrospinning today: an opportune time for an emerging polymer process. Prog Polym Sci. 2016; 56:116–166.

20. Niu H, Lin T, Wang X. Needleless electrospinning: developments and performances. Text Res J. 2009;79(14):1312–1319.

21. Farhaj S, Conway BR, Ghori MU. Nanofibres in drug delivery applications. Fibers (Basel). 2023;11(2):21. doi:10.3390/fib11020021.

22. Kim SE, Heo DN, Lee JB. Electrospun nanofibers for tissue engineering: advances in design and applications. Biomater Res. 2023;27(1):29.

23. Medeiros ES, Glenn GM, Klamczynski AP. Solution blow spinning: a new method to produce micro- and nanofibers from polymer solutions. J Appl Polym Sci. 2009;113(4):2322–2330.

24. Chahat Manish Patel, Kantilal. B. Narkhede, Anuradha Prajapati, Sachin.B. Narkhede, Shailesh Luhar. A Rising Emerge of Electrospun Nanofibers: Wound Healing, Preparation, Applications and Challenges. Asian Journal of Pharmacy and Technology. 2025; 15(1):48-0.

25. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol. 2003;21(10):1171–1178.

26. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide–amphiphile nanofibers. Science. 2001;294(5547):1684–1688.

27. Nam J, Huang Y, Agarwal S, Lannutti J. Improved cellular infiltration in electrospun fiber via engineered porosity. Tissue Eng. 2007;13(9):2249–2257.

28. Huang ZM, Zhang YZ, Kotaki M, Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol. 2003;63(15):2223–2253.

29. Cui W, Zhou Y, Chang J. Surface modification of electrospun fibers with biological macromolecules for tissue engineering. Mater Sci Eng C. 2010;30(3):438–444.

30. Chen X, Xu Y, Liang C. Surface functionalization of nanofibers for biomedical applications. Appl Surf Sci 2022; 589:153053.

31. Li X, Chen S, Zhang B. Surface-modified electrospun PCL/gelatin nanofibers for enhanced cell adhesion and biocompatibility. J Biomater Appl. 2021;36(3):453–464.

32. Kenawy ER, Bowlin GL, Mansfield K. Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinyl acetate) and poly (lactic acid) nanofiber blends. J Control Release. 2002;81(1–2):57–64.

33. Katti DS, Robinson KW, Ko FK, Laurencin CT. Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J Biomed Mater Res B. 2004;70(2):286–296.

34. Prachi Ganesh Chaudhari, Sunila A. Patil, S.P. Pawar. A Controlled Release Drug Delivery Systems. Asian Journal of Pharmacy and Technology. 2025; 15(2):197-4.

35. Li H, Chen Y, Li J. Core–shell structured insulin-loaded PVA/PCL nanofibers for sustained release. Int J Pharm.2020; 582:119340.

36. Ghosal K, Agatemor C, Škorić L. Electrospun nanofibers for drug delivery applications. J Drug Deliv Sci Technol .2019;53:101101.

37. Li X, Kanjwal MA, Lin L, Chronakis IS. Electrospun polyvinyl-alcohol nanofibers as drug delivery systems: optimization and release behavior. J Nanosci Nanotechnol. 2013;13(1):674–682.

38. Jiang T, Carbone EJ, Lo KW, Laurencin CT. Electrospinning of polymer nanofibers for tissue regeneration. Prog Polym Sci.2015; 46:1–34.

39. Al-Abduljabbar A, Al-Essa L, Al-Ghamdi S. Electrospun polymer nanofibers: processing, properties, and applications.

40. Jafari H, Pirouzfar V, Sarmadi M. Folic acid-functionalized nanofibers for targeted delivery of anticancer agents. Int J Pharm. 2022; 619:121736.

41. Jalaja K, James NR, Raj DK. Magnetic nanofibers for drug delivery: a review. J Magn Magn Mater. 2019; 469:456–472.

42. Fang J, Niu H, Lin T, Wang X. Applications of electrospun nanofibers in drug delivery systems. J Nanosci Nanotechnol. 2010;10(9):5564–5580.

43. Wang Y, Wu J, Wei Y, et al. Temperature-sensitive nanofibers for controlled release of therapeutics. J Mater Chem B. 2020;8(8):1846–1860.

44. Nair RS, Dhivya S, Rajendran N, et al. Enzyme-responsive electrospun nanofibers for localized delivery of therapeutics. ACS Biomater Sci Eng. 2022;8(2):698–708.

45. Kim J, Lee H, Kim JH. Light-triggered release from nanofiber matrices for on-demand drug delivery. Adv Funct Mater. 2019;29(21):1807557.

46. Gao Y, Kuang X, Liu J. Sustained release of paclitaxel from electrospun fibers for localized chemotherapy. Mater Sci Eng C.2021; 120:111697.

47. Wu J, Hong Y. Enhancing anticancer efficacy using nanofibers for co-delivery of siRNA and chemotherapeutic agents. Biomater Sci. 2022;10(15):4290–4301.

48. Sahoo S, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for tissue engineering. J Control Release. 2005;103(3):441–450.

49. Vasita R, Katti DSK. Nanofibers and their applications in tissue engineering. Int J Nanomedicine. 2006;1(1):1–15.

50. Xie X, Chen Y, Wang X. Electrospinning nanofiber scaffolds for soft and hard tissue regeneration. J Mater Sci Technol.2020; 59:243 –261.

51. Nemati S. Current progress in application of polymeric nanofibers to tissue engineering. Nano Convergence.2019;6:25.

52. Owida HA. Recent applications of electrospun nanofibrous scaffold in tissue engineering. Adv Skin Wound Care. 2022.

53. Flores-Rojas GG. Electrospun scaffolds for tissue engineering: a review. Materials. 2023;3(3):31.

54. Bhardwaj N, Kundu SC. Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv. 2010;28(3):325–347.

55. Ki CS, Baek DH, Gang KD. Characterization of gelatin nanofiber prepared from gelatin–formic acid solution. Polymer. 2005;46(14):5094–5102.

56. Soto D, Martucci JF, Scoponi M. Solution blow spinning for nanofiber wound dressings. Mater Sci Eng C. 2021; 120:111737.

57. Yu DG, Zhu LM, Branford-White C. Coaxial electrospinning for preparing polyacrylonitrile/poly (vinyl alcohol) core–shell nanofibers. Colloid Polym Sci. 2011;289(7):933–941.

58. Mukesh Rani, Vipasha Sharma. Medical Implants: An Overview, Innovation and Future Prospects. Asian Journal of Pharmacy and Technology. 2025; 15(2):157-5.

59. Abhishek Kanugo, Aparajita Chakravarti. Recent Advances in the Biomedical Applications of Hydrogels. Asian Journal of Pharmacy and Technology. 2025; 15(3):289-5.

60. Rathod Pallavi Vasant, Pagar Swati Appasaheb, Dube Shubhada Bhausaheb, Musmade Deepak Sitaram. Review on Organ on Chip. Asian J. Pharm. Tech. 2021; 11(1):66-71.

61. T.G. Rukari, P.A. Gavali, V.J. Patil, S.S. Gaonakr, K.S. Rathod, Y.M. Patil, Y.R. Dhongade, V.A. Jagtap. Innovative Vesicular Drug Delivery System of Ibuprofen with Unsaturated Fatty Acids: Formulation and Evaluation. Asian Journal of Pharmacy and Technology. 2024; 14(4):319-4.

62. Nawale Sejal Navnath, Nikam Unnati Sahebrao. Nanomedicines: Nano based Drug Delivery Systems Challenges and Future of nanomedicines. Asian Journal of Pharmacy and Technology. 2024; 14(2):135-0.

63. Parikshit Pise. A Review on Nanoparticle-Loaded Hydrogels for Extended Drug Release. Asian Journal of Pharmacy and Technology. Tech. 2024; 14(1):55-8.

64. Ghadge Dhairyasheel, Yadav Adhikrao, Gharge Varsha. Design and Development of Solid Self-Microemulsifying Drug Delivery of Gefitinib. Asian J. Pharm. Tech. 2018; 8 (4):193-199.

Received on 21.11.2025 Revised on 27.01.2026

Accepted on 28.02.2026 Published on 04.07.2026

Available online from July 18, 2026

Asian J. Pharm. Tech. 2026; 16(3):282-292.

DOI: 10.52711/2231-5713.2026.00040

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Category	Examples	Key Features / Advantages
Natural Polymers	Collagen, Gelatin, Silk Fibroin, Elastin	• Contain native cell-binding motifs (e.g., RGD) that promote excellent cell adhesion and proliferation. • High biocompatibility and biomimicry of ECM.
Natural Polymers (Polysaccharides)	Chitosan, Hyaluronic Acid (HA), Alginate, Cellulose derivatives	• Provide bioactivity: chitosan has intrinsic antimicrobial action; HA enhances cell migration; alginate offers high water affinity and gelation. • Often blended with synthetic polymers to improve spinnability.
Inorganic Fibers / Hybrid Systems	Bioactive glasses, Ceramics (HA, TCP), Metal oxides (TiO₂, ZnO)	Improve mineralization and osteoconductivity in applications involving bone tissue engineering.

Application Area	Description / Key Role	Examples of Nanofiber System	Results and Benefits	Reference
Cancer Therapy	Chemotherapeutic medications are given directly to the body to reduce systemic toxicity. Combined chemotherapy and gene therapy that uses multifunctional nanofibers	PLGA nanofibers infused with paclitaxel Hybrid nanofibers made of siRNA and doxorubicin.	For more than four weeks, it had an anticancer effect that lasted. Drug resistance can be fought by dual action (cytotoxicity + gene silencing).	41.
Wound Healing	To encourage healing to avoid infections, nanofibers serve as drug-eluting wound dressings.	Nanofibers with ciprofloxacin and curcumin in them.	Antimicrobial and antioxidant properties, expedited wound healing.	39,40.
Localised Administration (Implant/Transdermal)	Breathable nanofiber mats make it feasible for controlled medication to get through the skin. Biodegradable implanted nanofiber technology.	Electrospun patches with nanofibers that go through the skin. Nanofibers made of polymer that can be implanted.	Enhanced comfort and consistent drug absorption. localised release without surgical removal.	42.